CERS6 as: GTAGTGAAGGTCAGTTGTGAGTGG CERS2 5′ UTR s: GAGCAGACGGAGTACACGGA CERS2 Ex4 as: ACGGAACCAACGCTCTACCTG Figure S1 . Metabolism of sphingolipids. The biosynthetic pathway of sphingolipids relevant to this study is shown. Serine is incorporated into both sphingolipids and glycerolipids. Galactose is mainly incorporated into glycosphingolipids (GSLs), but galactose is also converted to glycerol-3-phosphate (glycerol-3-P) and acetyl-CoA to be incorporated into glycerolipids. Red letters indicate the enzymes involved in this study. SM, sphingomyelin; GlcCer, glucosylceramide; LacCer, lactosylceramide; Gb3, globotriaosylceramide; GalCer, galactosylceramide; Gb2, galabiosylceramide (Galα1-4GalCer); PS, phosphatidylserine; PE, phosphatidylethanolamine; PC, phosphatidylcholine; CERS, ceramide synthase; SMS, sphingomyelin synthase; UGCG; UDP-glucose: ceramide glucosyltransferase (GlcCer synthase); GSLs; glycosphingolipids; P, phosphate. . Blue box, exon 1; pink box, exon 2; light blue box, exon 3; white box, exon 4; black box, extended exon 2; blue line box, splicing donor and acceptor; yellow box, start codon; (B) RT-PCR analysis of CERS2 in CERS2-deficient mutants. Primers bound to the 5′ untranslated region (5′ UTR) (exon 1) and exon 4 of CERS2 were used. P, parent cell line; 16, TAL-CERS2#16 clone; 18, TAL-CERS2#18 clone; 13, TAL-CERS2#13 clone. Note that a short transcript was observed in the mutants but not the parent cells, which indicates the exon 2-skipped transcript shown in (C-E); (C-E) schematic diagrams of CERS2 transcripts observed in (C) TAL-CERS2#16 clone, (D) TAL-CERS2#18 clone, and (E) TAL-CERS2#13 clone. The numbers of CERS2 transcripts analyzed in TAL-CERS2 clones are specified on the right of the sequences. Transcript D (a) contains the wild-type CERS2 open reading frame, but it does not follow the Kozak rule because the critical -3 position from the start codon was guanine in the wild-type transcript, whereas it was changed to cytosine in the transcript C (a) (CTGATG)). Colored boxes indicate the same as (A). Red dashes and boxes indicate deletions. Figure 5A and the [ 14 C]serine-labeled ceramide shown in Figure 5B . The method was as described in Figure S3B . Figure S8 . Western blot analysis of UGCG in UGCG-overexpressed TAL-CERS2#18 cells. These images are the whole ones of Figure 6A . (-) , no transfection; UGCG, UGCG cDNA overexpression. 
